GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Infusions Ltd (DHA:ORIONINFU) » Definitions » Market Cap

Orion Infusions (DHA:ORIONINFU) Market Cap : BDT12,148.7 Mil (As of Apr. 28, 2024)


View and export this data going back to . Start your Free Trial

What is Orion Infusions Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Orion Infusions's share price for the quarter that ended in Dec. 2023 was BDT361.3. Orion Infusions's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 20.4 Mil. Therefore, Orion Infusions's market cap for the quarter that ended in Dec. 2023 was BDT7,356.0 Mil.

Orion Infusions's quarterly market cap declined from Jun. 2023 (BDT6,851.1 Mil) to Sep. 2023 (BDT6,761.5 Mil) but then increased from Sep. 2023 (BDT6,761.5 Mil) to Dec. 2023 (BDT7,356.0 Mil).

Orion Infusions's annual market cap increased from Jun. 2021 (BDT1,394.6 Mil) to Jun. 2022 (BDT1,777.4 Mil) and increased from Jun. 2022 (BDT1,777.4 Mil) to Jun. 2023 (BDT6,851.1 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Orion Infusions's Enterprise Value for Today is BDT12,473.6 Mil.


Orion Infusions Market Cap Historical Data

The historical data trend for Orion Infusions's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Infusions Market Cap Chart

Orion Infusions Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,168.65 1,467.94 1,394.65 1,777.41 6,851.07

Orion Infusions Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,737.76 5,468.64 6,851.07 6,761.49 7,356.00

Competitive Comparison of Orion Infusions's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Orion Infusions's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Infusions's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orion Infusions's Market Cap distribution charts can be found below:

* The bar in red indicates where Orion Infusions's Market Cap falls into.



Orion Infusions Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Orion Infusions's Market Cap for the fiscal year that ended in Jun. 2023 is calculated as

Market Cap (A: Jun. 2023 )=Share Price (A: Jun. 2023 )*Shares Outstanding (EOP) (A: Jun. 2023 )
=BDT336.5*20.3598
=BDT6,851.1

Orion Infusions's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=BDT361.3*20.3598
=BDT7,356.0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orion Infusions  (DHA:ORIONINFU) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Orion Infusions Market Cap Related Terms

Thank you for viewing the detailed overview of Orion Infusions's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Infusions (DHA:ORIONINFU) Business Description

Traded in Other Exchanges
N/A
Address
Tejgaon Industrial Area, No. 153-154, Dhaka, BGD, 1208
Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.

Orion Infusions (DHA:ORIONINFU) Headlines

No Headlines